Hologic Stock News

Hologic Launches Validated Pooling Protocol for COVID-19 Testing

Integra's (IART) second-quarter 2020 results reflect disappointing segmental performance due to coronavirus-led business disruptions.

The

Globus Medical (GMED) witnesses dismal segmental and international performance in the second quarter owing to pandemic-led adversities.

The

Calgary, Alberta--(Newsfile Corp. - August 7, 2020) - Braveheart Resources Inc. (TSXV: BHT) (OTCQB: RIINF) ("Braveheart" or the "Company"). At the request of the Investment Industry Regulatory Organiz

The Global Coronavirus Test Kits Market will grow by USD 320.29 mn during 2020-2024

Calgary, Alberta--(Newsfile Corp. - August 6, 2020) -  Braveheart Resources Inc. (TSXV: BHT) (OTCQB: RIINF) ("Braveheart" or the "Company") is pleased to announce that it has closed a first tranche o

NuVasive's (NUVA) operating segments experienced slowdown in second-quarter volumes due to the coronavirus pandemic.

Hologic (HOLX) is seeing positive earnings estimate revisions, suggesting that it could be a solid choice for investors.

Raymond James analyst Jayson Bedford maintained a Buy rating on Hologic (HOLX – Research Report) on June 8. The company’s

Kahn Brothers’ 13F portfolio value increased from $547M to $592M this quarter. BP and Patterson-UTI were increased while reducing Hologic and Merck.

The Global Point-of-care Ultrasound Systems Market will grow by USD 853.28 mn during 2020-2024

CVS Health's (CVS) Health Care Benefits segment registers membership growth in Q2.

Although Intersect ENT's (XENT) Q2 sales are down year over year, it's stronger than expected, led by the return of sinus surgery procedures using PROPEL.